Article Information
History
- August 7, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Fernando Gonzalez-Ortiz, MD, MSc1,2,#,*,
- Bjørn-Eivind Kirsebom, PhD3,4,5,#,*,
- Yara Yakoub, MSc6,
- Julia K. Gundersen, MD, PhD5,7,
- Lene Pålhaugen, MD5,8,
- Knut Waterloo, PhD3,4,
- Per Selnes, MD, PhD5,8,
- Jonas Alexander Jarholm, MD5,8,
- Berglind Gísladóttir, MSc5,
- Arvid Rongve, MD, PhD9,10,
- Ragnhild Eide Skogseth, MD, PhD11,12,
- Geir Bråthen, MD, PhD13,14,
- Dag Aarsland, MD, PhD15,16,
- Michael Turton, PhD17,
- Peter Harrison, MA17,
- Henrik Zetterberg, MD, PhD1,2,18,19,20,21,
- Sylvia Villeneuve, PhD6,
- PREVENT AD research group6,
- Tormod Fladby, MD, PhD5,8,† and
- Kaj Blennow, MD, PhD1,2,22,23,†
- 1Inst. of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden
- 2Clinical Neurochemistry Lab, Sahlgrenska University Hospital, Mölndal, Sweden
- 3Department of Neurology, University Hospital of North Norway, Tromsø, Norway
- 4Department of Psychology, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway
- 5Department of Neurology, Akershus University Hospital, Lørenskog, Norway
- 6Douglas Mental Health University Institute, Centre for Studies on the Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada
- 7Division of Physiology, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
- 8University of Oslo, Institute for Clinical Medicine, Campus Ahus
- 9Department of Neuropsychology, Haugesund Hospital, Haugesund, Norway
- 10Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway
- 11Department of Geriatric Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway
- 12Department of Clinical Sciences, Faculty of Medicine, University of Bergen, Norway
- 13Department of Neurology and Clinical Neurophysiology, University Hospital of Trondheim, Trondheim, Norway
- 14Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
- 15Centre for Age-Related Diseases. Stavanger University Hospital Stavanger, Norway
- 16Department of Old Age Psychiatry. Institute of psychiatry, Psychology and Neuroscience King’s College London, London, UK
- 17Bioventix Plc, 7 Romans Business Park, East Street, Farnham, Surrey GU9 7SX, UK
- 18Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- 19UK Dementia Research Institute at UCL, London, UK
- 20Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China
- 21Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
- 22Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France
- 23Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, P.R. China
- ↵#Correspondence:
Fernando Gonzalez-Ortiz, Clinical Neurochemistry Lab House V3, floor 2 Mölndal Hospital Street Address: Biskopsbogatan 27 SE-43180 Mölndal, Sweden. Email: fernando.gonzalez.ortiz{at}gu.se, Bjørn-Eivind Kirsebom, Neurology department, University Hospital of North Norway Hansine Hansens veg 67, 9019 Tromsø, Norway. Email: bjorneivind.kirsebom{at}gmail.com
Posted August 07, 2024.
Blood p-tau association with cognitive status and future memory decline in early Alzheimer’s disease
